Aethon Therapeutics

Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness. Aethon's unique anti-drug-peptide conjugate/MHC antibodies are intended to be employed in conjunction with TCI of RAS, EGFR,…


Founded
2022
Headcount
13
Open roles
0
Last raised
Series A · $30M

SECTION I · THE BRIEF

Inside Aethon Therapeutics

Brief #79637Updated 18 NOV 2025NEW YORKMEDICAL ORGANIZATIONSSERIES A
Employbl Dossier

Aethon Therapeutics

Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness. Aethon's unique anti-drug-peptide conjugate/MHC antibodies are intended to be employed in conjunction…

Founded
2022
Headcount
13
Open roles
0
Last raised
Series A · $30M
Section II · Premium ProfileMembers only
  • 01Engineering interview process at Aethon TherapeuticsLocked
  • 02Tech stack & infrastructure choicesLocked
  • 03Culture & day-to-day work styleLocked
  • 04Why join now vs. 6 months from nowLocked
  • 05Hiring focus & open headcount by teamLocked
  • 06Comp philosophy and band contextLocked

7-day free trial · $25/mo · cancel anytime


LEADERSHIP

Founders & key people

Benjamin Neel
Shohei KoideShohei Koide

OPEN ROLES

Hiring at Aethon Therapeutics

No open roles listed right now. Check back soon or search all jobs →


FUNDING

Capital raised

Total Amount Raised: $30,000,000

Aethon Therapeutics Funding Rounds

  • Series A

    $30,000,000

  • Series A

    $30,000,000

    Series A Investors

    NYU Langone Medical Center
    Apple Tree Partners
Funding info provided by Diffbot.

TAGS

Categorized in

Company Collections

These are collections Aethon Therapeutics is a part of. Click on the collection name to view similar companies.

Aethon Therapeutics' Tech Stack


LOCATIONS

Where they work

Aethon Therapeutics Headquarters Location

New York, NY, 11217

Loading map…